RN7SL60P

Across TCGA pan-cancer cohorts, RN7SL60P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL60P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL60P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL60P expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC, OV, and GBM are the cancer types where RN7SL60P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.665	0.300	.008	99	view →
OV	DFS	Tertile	III,IV	0.277	0.384	.012	42	view →
GBM	DFS	Tertile	All	0.137	0.273	.003	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
KIRP	DFS	Tertile	All	0.250	0.625	.003	15	view →
KIRC	DFS	Tertile	III,IV	0.221	0.505	.018	12	view →
LIHC	DFS	Tertile	III,IV	0.139	0.343	.040	12	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →
LUAD	DFS	Tertile	All	0.856	0.659	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL60P–HNSC (DFS)

Open the HNSC breakdown →